In some clinical studies, IFN-γ has the potential to improve monocyte dysfunction in sepsis patients by increasing mHLA-DR expression and TNF-α secretion [220] while reducing IL-10 expression, thus reversing immunosuppression [221]. This evidence concerns the gene IL10 and Sepsis.